• About Us
  • Mission & Vision
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Pipeline
  • Careers & Culture
  • Contact Us
• Disease Areas & Tests
  • Innovative Diagnostic Portfolio to Manage the Patient Journey
    • Our industry-leading GI diagnostic portfolio provides actionable results across the patient journey. From diagnosis to treatment, disease monitoring and through remission, the Prometheus suite of tests are purpose-built to confidently guide patient care decisions.
  • Precision-Guided Dosing
    • About PredictrPK
    • Infliximab
      • Induction
      • Maintenance
    • Adalimumab
  • Therapeutic Drug Monitoring
    • Anser IFX
    • Anser ADA
    • Anser VDZ
    • Anser UST
  • Inflammatory Bowel Disease
    • Monitr Crohn’s Disease
    • IBD sgi Diagnostic
    • Crohn’s Prognostic
    • RiskImmune

  • Thiopurine Management
    • TPMT Genetics
    • TPMT Enzyme
    • Thiopurine Metabolites
  • Celiac
    • Celiac Plus
    • Celiac Genetics
    • Celiac Serology
  • Additional Testing
    • FIBROSpect HCV
    • FIBROSpect NASH
    • LactoTYPE
• News & Events
  • News
  • Events
  • Videos
• Healthcare Providers
• Patients

Monitr Crohn’s Diseaseprometheuslabs2021-05-13T03:11:47-07:00